Injecting mice with healthy lung endothelial cells — specialized cells lining the inside of blood vessels — prevented, and in…
Forest Ray PhD
Forest Ray received his PhD in systems biology from Columbia University, where he developed tools to match drug side effects to other diseases. He has since worked as a journalist and science writer, covering topics from rare diseases to the intersection between environmental science and social justice. He currently lives in Long Beach, California.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Forest Ray PhD
Mice lacking a protein called FCHSD1 were protected from developing emphysema, a severe form of chronic obstructive pulmonary disease…
Preventing a specific type of cell death, called necroptosis, may provide a new way of treating chronic obstructive pulmonary…
Teva Pharmaceuticals has launched the first generic version of Perforomist (formoterol fumarate inhalation solution) for the treatment of…
Medical Mutual of Ohio now covers Spiration Valve System (SVS), Olympus‘ minimally invasive therapy for eligible patients with severe emphysema,…
The National Heart, Lung, and Blood Institute awarded $962,000 to a University of Buffalo researcher to develop risk models that…
Scientists have identified several genes associated with rapid lung function decline in former and current smokers that might help identify…
Scientists have found that a certain protein helps cells in the airways to clear away mucus, such as the mucus…
X-PLOâ‚‚R, a portable oxygen concentrator developed by Belluscura and its research partner Separation Design Group, has been cleared for…
As part of its Catalyst Grant program, the American Lung Association (ALA) has awarded $50,000 for a project aimed…